Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...

A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the ...

The way in which blood stem cells evolve over a lifespan differs greatly between humans and mice, new research reveals. The ...

In 2006, Shinya Yamanaka made a groundbreaking discovery that would win him the Nobel Prize in Physiology or Medicine just ...

Cooking up a batch of stem cells to treat illness or injury used to involve the ethically hairy practice of harvesting them from embryonic tissue. But in 2006, Japanese scientists identified a way ...

Only a few universities nationwide, including the University of Southern California and Harvard, offer courses that allow ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Sebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...

The cornea is the clear, outermost layer of the eye. Its outer border, the limbus, contains a large volume of healthy stem ...

Harvard Professor and Broad Institute member Paola Arlotta received the Momentum Award from the International Society of Stem ...